NexgenRx Inc.
NEGXF
$0.20
$0.00351.78%
Weiss Ratings | NEGXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Good | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | B- | |||
Rating Factors | NEGXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Fair | |||
Efficiency Index | Good | |||
Solvency Index | Excellent | |||
Total Return Index | Fair | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | NEGXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.22 | |||
Price History | NEGXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 0.00% | |||
30-Day Total Return | 0.00% | |||
60-Day Total Return | 0.00% | |||
90-Day Total Return | 0.00% | |||
Year to Date Total Return | 0.00% | |||
1-Year Total Return | 0.00% | |||
2-Year Total Return | -1.12% | |||
3-Year Total Return | -61.65% | |||
5-Year Total Return | 57.11% | |||
52-Week High % Change | 0.00% | |||
52-Week Low % Change | 5.82% | |||
Price | NEGXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $0.20 | |||
52-Week Low Price | $0.19 | |||
52-Week Low Price (Date) | Sep 10, 2024 | |||
52-Week High Price (Date) | Oct 02, 2024 | |||
Valuation | NEGXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 12.34M | |||
Enterprise Value | 12.53M | |||
Price/Earnings (TTM) | 95.24 | |||
Earnings Per Share (TTM) | 0.00 | |||
Earnings Per Share Growth | -155.26% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 1.30 | |||
Price/Book (Q) | 2.98 | |||
Enterprise Value/Revenue (TTM) | 1.06 | |||
Price | $0.20 | |||
Enterprise Value/EBITDA (TTM) | 9.91 | |||
Enterprise Value/EBIT | 35.28 | |||
Market Cap Category | Nano Cap | |||
Dividends and Shares | NEGXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 76.68M | |||
Dividend Yield | 3.60% | |||
Div. Per Share (Most Recent) | $0.00 | |||
Dividend Per Share (TTM) | $0.01 | |||
Payout Ratio (TTM) | 337.22% | |||
Dividend Per Share (Most Recent) | $0.00 | |||
Company Info | NEGXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 416 695 3393 | |||
Address | 191 The West Mall Toronto, ON M9C 5L6 | |||
Website | www.nexgenrx.com | |||
Country | Canada | |||
Year Founded | 2003 | |||
Profitability | NEGXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 2.99% | |||
Profit Margin | 1.60% | |||
Management Effectiveness | NEGXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 0.98% | |||
Return on Equity | 3.09% | |||
Income Statement | NEGXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 11.40M | |||
Total Revenue (TTM) | 11.85M | |||
Revenue Per Share | $0.15 | |||
Gross Profit (TTM) | 9.19M | |||
EBITDA (TTM) | 1.26M | |||
EBIT (TTM) | 355.20K | |||
Net Income (TTM) | 189.70K | |||
Net Income Avl. to Common (TTM) | 68.40K | |||
Total Revenue Growth (Q YOY) | 20.64% | |||
Earnings Growth (Q YOY) | 212.21% | |||
EPS Diluted (TTM) | 0.00 | |||
EPS Diluted Growth (Q YOY) | 200.00% | |||
Balance Sheet | NEGXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 1.37M | |||
Cash Per Share (Q) | $0.02 | |||
Total Current Assets (Q) | 18.72M | |||
Total Preferred Equity (Q) | 1.22 | |||
Total Equity (Q) | 6.00M | |||
Current Ratio (Q) | 1.095 | |||
Book Value Per Share (Q) | $0.07 | |||
Total Assets (Q) | 23.39M | |||
Total Current Liabilities (Q) | 17.10M | |||
Total Debt (Q) | 346.80K | |||
Total Liabilities (Q) | 17.39M | |||
Total Common Equity (Q) | 4.78M | |||
Cash Flow | NEGXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -219.00K | |||
Cash from Financing (TTM) | -573.70K | |||
Net Change in Cash (TTM) | -73.50K | |||
Levered Free Cash Flow (TTM) | 532.80K | |||
Cash from Operations (TTM) | 719.40K | |||